APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER

LIVE

Serial Number

97723397

Owner

Phlow Corp.

Attorney

John R. Mills

First Use Date

Sep 13, 2022

Filing Date

Dec 19, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER Trademark

Serial Number: 97723397 • Registration: 7573291

APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER is a trademark filed by Phlow Corp. on December 19, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Phlow Corp. (12 trademarks)

424 Hull St., Suite 400
Richmond, VA 23224

Entity Type: 03

Legal Representation

Attorney of Record

John R. Mills

16 trademarks filed View all →

Correspondence Address

John R. Mills Mills IP Law, PLLC

1818 Library Street, Suite 500

Reston, VA 20190

United States

Trademark Details

Filing Date

December 19, 2022

Registration Date

November 19, 2024

First Use Anywhere

September 13, 2022

First Use in Commerce

December 12, 2022

Published for Opposition

May 16, 2023

Goods & Services

Pharmaceutical research and development

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

May 2, 2025 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 2, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 2, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 2, 2025 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 2, 2025 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 2, 2025 COAR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 19, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 19, 2024 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 15, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 15, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 18, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 18, 2024 AITU

USE AMENDMENT FILED

Jul 16, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Jul 16, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 18, 2024 EXRA

SOU EXTENSION 2 GRANTED

Jun 18, 2024 EX2G

SOU EXTENSION 2 FILED

Jun 18, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Jun 18, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 13, 2023 EXRA

SOU EXTENSION 1 GRANTED

Dec 11, 2023 EX1G

SOU EXTENSION 1 FILED

Dec 11, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 11, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 11, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 16, 2023 NPUB

PUBLISHED FOR OPPOSITION

May 16, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 26, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 7, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 6, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 5, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 5, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 31, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 31, 2023 GNRT

NON-FINAL ACTION WRITTEN

Mar 31, 2023 CNRT

ASSIGNED TO EXAMINER

Mar 28, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 15, 2023 NWOS

NEW APPLICATION ENTERED

Dec 22, 2022 NWAP

Related Trademarks

More from this Owner

CDMOX BY PHLOW

APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER

More in Same Class

M MURF.AI

Serial #97722778